Germani Marcelo, Munoz-Lora Victor R M, Carnevali Ana C N, Geroldo Adriana Marques, Teixeira Fernanda Fogolin, Giro Gabriela
Aesthet Surg J Open Forum. 2025 Jan 11;7:ojaf002. doi: 10.1093/asjof/ojaf002. eCollection 2025.
Minimally invasive aesthetic procedures, such as the use of polydioxanone (PDO) threads, are increasingly popular for facial rejuvenation.
This study investigates the impact of the number of PDO threads on tissue displacement, volume changes, and patient satisfaction.
This randomized controlled trial involved 22 patients seeking facial lifting using PDO threads. Participants were divided into 2 groups: G1 with 3 threads per hemiface and G2 with 6 threads per hemiface. Three-dimensional stereophotogrammetry was used to evaluate volumetric changes and tissue displacement at baseline, 20 days, and 60 days posttreatment. Patient satisfaction was assessed using the Global Aesthetic Improvement Scale (GAIS).
Significant volumetric changes were observed over time in both midface and lower face regions ( < .05), but no significant intergroup differences were found ( > .6). Tissue displacement showed statistical significance over time ( = .039) but not between groups ( = .821). GAIS scores did not differ significantly between groups or between patients and specialists. Adverse events were minor and transient, primarily involving pain.
The number of PDO threads used did not significantly influence sustained lifting outcomes or patient satisfaction. Initial improvements in volume and tissue displacement diminished by 60 days, suggesting that additional threads do not enhance long-term efficacy. Further studies with longer follow-up are needed to better understand collagen stimulation's potential role in lasting effects.
微创美容手术,如使用聚对二氧环己酮(PDO)线,在面部年轻化方面越来越受欢迎。
本研究调查PDO线的数量对组织移位、体积变化和患者满意度的影响。
这项随机对照试验纳入了22名寻求使用PDO线进行面部提升的患者。参与者被分为两组:G1组每半侧面部使用3根线,G2组每半侧面部使用6根线。使用三维立体摄影测量法评估治疗前、治疗后20天和60天的体积变化和组织移位。使用全球美容改善量表(GAIS)评估患者满意度。
在中面部和下面部区域均观察到随时间有显著的体积变化(P<0.05),但未发现组间有显著差异(P>0.6)。组织移位随时间显示出统计学意义(P = 0.039),但组间无差异(P = 0.821)。GAIS评分在组间或患者与专家之间无显著差异。不良事件轻微且短暂,主要涉及疼痛。
使用的PDO线数量对持续提升效果或患者满意度没有显著影响。体积和组织移位的初始改善在60天时减弱,这表明额外的线并不会增强长期疗效。需要进行更长随访时间的进一步研究,以更好地了解胶原蛋白刺激在持久效果中的潜在作用。